Author

Giorgia Zadra

Brigham and Women's HospitalORCID 0000-0002-8123-1358Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Massimo F. LodaiD· 2 shared Adrienne LuomaiD· 1 shared Alessandro BarberisiD· 1 shared Anna de PoloiD· 1 shared Avery S. FeitiD· 1 shared Caroline F. RibeiroiD· 1 shared Colm M. MorrisseyiD· 1 shared Connor A. BelliD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Massimo F. LodaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 21, 2026

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression

Silvia Daniele Rodrigues, Caroline F. Ribeiro, Giuseppe Nicolò Fanelli…·Massimo F. Loda

This study shows that inhibiting de novo lipogenesis and supplementing with PUFAs suppresses prostate cancer progression by inducing oxidative stress and cell death.

DOI 10.64898/2026.03.25.714193

humanmouse

𝕏 PostBluesky

GenomicsNature CommunicationsPeer-reviewedMay 13, 2022

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Xintao Qiu, Nadia Boufaied, Tarek Hallal…·David P. Labbé

This study shows MYC overexpression disrupts AR transcriptional pause release, promoting aggressive prostate cancer progression.

160 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky